Glucagon-like peptide-1 agonists may raise infection risk after ankle fusion procedures

Presented results showed glucagon-like peptide-1 agonists may predispose patients with type 2 diabetes undergoing tibiotalar fusion, subtalar fusion or triple arthrodesis to postoperative infection.
Michael F. Levidy, MD, a PGY-2 at the Milton S. Hershey Medical Center at Penn State Health, and colleagues retrospectively performed a database query using CPT and ICD codes to identify patients with type 2 diabetes who underwent tibiotalar fusion, subtalar fusion or triple arthrodesis between 2005 and 2024. Levidy and colleagues categorized patients into two propensity-matched cohorts of 708

Presented results showed glucagon-like peptide-1 agonists may predispose patients with type 2 diabetes undergoing tibiotalar fusion, subtalar fusion or triple arthrodesis to postoperative infection.
Michael F. Levidy, MD, a PGY-2 at the Milton S. Hershey Medical Center at Penn State Health, and colleagues retrospectively performed a database query using CPT and ICD codes to identify patients with type 2 diabetes who underwent tibiotalar fusion, subtalar fusion or triple arthrodesis between 2005 and 2024. Levidy and colleagues categorized patients into two propensity-matched cohorts of 708